ESGO Webcast & Video Podcast of the 17th International Meeting of the European Society of Gynaecological Oncology (ESGO) powered by - MULTIWEBCAST

Username :
Password :

Warning ! The cookie feature is disabled in your browser. Some features may not work properly.
Click here to learn how to activate your cookies.

17th International Meeting of the European Society of Gynaecological Oncology (ESGO)

LIST OF PRESENTATIONS/COURSES

LISTING OF ePOSTERS

OTHER WEBCASTS

ePosters

BROWSE:

ALL ePOSTERS

PRESENTERS

« PREVIOUS NEXT »

Topics

Breast Cancer (4)
Cervical Cancer (12)
Diagnostics (6)
Endometrial Cancer (11)
Fertility / pregnancy (1)
Fertility Sparing in Gynaecologic Cancer (1)
Miscellaneous (1)
Ovarian and tubal cancer (1)
Ovarian Cancer (17)
Prevention of Gynaecologic Cancer (5)
Quality of Life after Treatment of Gynaecologic Ca (1)
Translational Research (1)
Trophoblastic Diseases (1)

Risk of primary and contralateral breast cancer after ovarian cancer in brca1/2 mutation carriers; is a prophylactic mastectomy justified?

Peggy MLH Vencken

New generation of designed and synthesized nanobioconjugates for direct targeting and systemic treatment of her2-positive breast cancer

Julia Ljubimova

Evolutionary pathways in brca1- associated breast tumors and their clinical implications

Filipe C Martins

to be announced!

Skin sparing mastectomy and immediate breast reconstruction, oncological safety and outcome.

Sara Al-Reefy

Early experience of robotic pelvic exenteration compared to open pelvic exenteration for treatment of gynecologic malignancy.

PETER LIM

Are the more number of pelvic nodes removed increase the incidence of positive node and survival in cervical cancer patients?

Prapaporn Suprasert

Class iii nerve-sparing radical hysterectomy versus standard class iii radical hysterectomy: an observational study

Antonino Ditto

Robotic nerve-sparing versus laparoscopic without nerve-sparing radical hysterectomy in early cervical cancer : urinary diseases

Benjamin Merlot

Do we need to extend the para-aortic lymphadenectomy above the inferior mesenteric artery in locally advanced cervical cancers ?

Benjamin Merlot

The role of ultrasound in planning fertility sparing surgery and individual treatment in early stage cervical cancer

Daniela Fischerova

Does surgical approach influence the outcomes of locally advanced stage cervical cancer after neoadjuvant chemotherapy?

Stefano UCCELLA

Weekly topotecan and cisplatin as neo-adjuvant chemotherapy for locally-advanced squamous cervical carcinoma: preliminary results of a phase ii multicentric study

Flavia Zanaboni

Prospective comparison between laparoscopic and laparotomic radical hysterectomy in the treatment of ib-iia cervical cancer.

Andrea Maneo

High concordance of hrhpv testing between self-collected brush samples and physician-taken samples

Maaike Dijkstra

Survival after pelvic exenteration for cervical cancer: a retrospective multicentric study of 158 patients.

Martina Rossi

Surgical treatment of lymph node metastases in stage ib cervical cancer. laterally extended parametrectomy: 5 years follow-up.

Zoltan Novak

Near-infrared (nir) fluorescence imaging for sentinel lymph node detection in cervical and vulvar cancer: a feasibility study.

Cornelis D De Kroon

Factors influencing lymph node counts in laparoscopic lymhadenectomy

Jekaterina Vasiljeva

Predicting the risk of malignancy for an ovarian tumor by combining imaging and ova1

Frederick Ueland

Dynamic spectral imaging colposcopy: higher sensitivity for detection of premalignant cervical lesions

Afra Zaal

Diagnostic performance of preoperative level of platelet count in women with ovarian masses

Evangelia Myriokefalitaki

Conservative management and ultrasonographic longitudinal follow-up of borderline ovarian tumors recurrences after fertility sparing surgery

Dorella Franchi

Metformin prevents recurrence following after progestin therapy for fertility-sparing treatment in young women with endometrial cancer or atypical endometrial hyperplasia

Akira mitsuhashi

He4 as prognostic marker in endometrial cancer

Irene Mutz-Dehbalaie

Microrna-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting bmi-1

Peixin Dong

Pegylated liposomal doxorubicin and carboplatin in gynecologic sarcoma. a phase-ii trial of the ago study group

Lars Hanker

Synucelin-? can predict clinical outcome in women with endometrial adenocarcinoma.

Paulette Mhawech-fauceglia

to be announced!

Use of bisphosphonates is associated with a major reduction for endometrial cancer

Ofer Lavie

Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mtor) in endometrial cancer cells

Ya Xie

to be announced!

The impact of tumor morcellation during surgery on the outcomes of patients with apparently early low grade endometrial stromal sarcoma

JEONG-YEOL PARK

The relevance of cervical cytology in serous versus endometrioid endometrial cancer patients

Yvette Geels

Effect of surgeon and hospital volume on outcomes for women with endometrial cancer who undergo laparoscopic hysterectomy

Jason Wright

A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin in localized uterine sarcomas. results on 81 patients

Patricia Pautier

Possibility of fertility preservation in young cancer patients.

Marina Kiseleva

Meta-analysis of oral or intrauterine progestin treatment for complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma

Andreas Obermair

Overexpression of enolase 1 in brain metastasis from gynecological malignancies: a proteomic analysis using formalin-fixed paraffin-embedded tissues

Ayako yoshida

Improved 8-years survival for ovarian cancer patients figo stage iiic operated at teaching hospitals in norway

Witold Szczesny

Effective ovarian cancer (ovca) screening using transvaginal ultrasound (tvs): perspectives from the kentucky experience

Edward Pavlik

Correlation of dose-intensity and efficacy of gemcitabine/carboplatin in platinum-sensitive recurrent ovarian cancer (psoc): subanalysis of the ago-ovar 2.5 phase-iii-trial

Sven Mahner

Diaphragmatic surgery during primary cytoreduction for advanced ovarian cancer: peritoneal stripping versus diaphragmatic resection.

Ignacio Zapardiel

Activity of designed ankyrin repeat-proteins (darpins) targeted for dnmt1 and conjugated to docetaxel against mutated ovarian cancer stem cells (mocscs).

J. Giannios

to be announced!

Mtor is a pharmacological target for the treatment of the ovarian granulosa cell tumor

Marie-Eve Nadeau

Investigation into the biological functions of hepatocyte nuclear factor-1beta in the clear cell adenocarcinoma of ovary

Hiroshi Shigetomi

Borderline ovarian tumours: routine hospital follow-up is no longer justified

Rachel O'Donnell

Does age of tumor onset change over the generations in families at increased risk for breast and ovarian cancer ?

Karin Leunen

Prognosis of the micropapillary pattern in patients treated for stage ii and iii serous borderline tumors of the ovary.

Catherine Uzan

Hand assisted laparoscopy to assess resecability of peritoneal carcinomatosis in peritoneal, fallopian tube and ovarian cancers

Anne Sophie Bats

Development and validation of a nomogram to predict survival in calypso and ago-2.5 patients with platinum sensitive recurrent ovarian cancer

Chee Lee

Trabectedin+pld significantly prolongs survival in platinum sensitive + partially platinum sensitive relapsed ovarian cancer patients in comparison to pld alone

Ignace B. Vergote

Potentiation of a p53-slp vaccine by cyclophosphamide in ovarian cancer, a single arm phase ii study

Renee Vermeij

Programmed death-1 ligands are expressed in the majority of advanced serous epithelial ovarian cancer

Renee Vermeij

Efficacy of platinum/taxane-based chemotherapy in elderly with ovarian cancer: explorative analysis of three phase iii trials from the ago-study-group

Felix Hilpert

Analysis of metastatic pericolonic lymph nodes in patients with advance stage ovarian cancer

Michele Peiretti

Ovarian cancer survival in australia, canada, denmark, norway and the united kingdom (1995-2007): the international cancer benchmarking partnership

John Butler

Human papillomavirus-type-specific risk of progression from lsil/hsil to cin3 or invasive cervical cancer in japan

Noriaki Sakuragi

to be announced!

Evaluating the anti-cancerous effect of dendrosomal nano-curcumin in vitro & in vivo

Esmaeil babaei

Oral contraceptives and risk of ovarian and breast cancers in brca mutation carriers: meta-analysis.

David Cibula

to be announced!

Surepath liquid-based cytology improved the detection of high grade lesions in remote rural areas. preliminary results of rodeo study.

José Humberto Fregnani

Risk reducing salpingo-oophorectomy, a ten-year experience at institut curie.

Virginie Fourchotte

Urinary symptoms in gynecological cancer survivors impact daily life and sexual functioning

Gail Dunberger

Hla-e expression by gynecological cancers restrains tumor-infiltrating cd8+ t lymphocytes

Marloes J.M. Gooden

Contribution of referent pathologists to the quality of trophoblastic disease diagnosis.

Jessica Clerc

Disclaimer ^{AMENDED ON January 29, 2009} | Technical Support

USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.